Topic
Private Credit Research
Within the private credit landscape, researchers emphasize the continued importance of private markets and direct lending as essential tools for diversifying portfolios amidst heightened geopolitical uncertainty and credit stress. While direct lending remains supported, analysts advocate for strict selectivity with a bias toward non-cyclical sectors and infrastructure for inflation-linked income. Credit strategies demonstrated resilience with positive returns in early 2026, though a more defensive posture is emerging through the prioritization of Relative Value and Fixed Income Relative Value sub-strategies. Solid corporate fundamentals and projected S&P 500 EPS growth of 20% support the credit outlook, even as high government deficits pose long-term risks to yields and necessitate a focus on shorter-duration fixed income. Additionally, the massive expansion in AI-related demand, with a projected $1.7 trillion TAM by 2030, and the evolution of biotech into a compounding asset class are creating new long-term investment opportunities for credit providers. Collectively, these insights suggest a research direction focused on resilient, innovation-driven sectors to navigate a goldilocks environment disrupted by macro volatility.
4639 reports available
All reports
Page 76 of 194
FX Daily
Crédit Agricole Corporate and Investment Bank · Jun 9, 2026
Rhythm Pharmaceuticals Key Takeaways
Goldman Sachs · Jun 9, 2026
Chinese Capital Returns To Australia
Deutsche Bank · Jun 9, 2026
On The Road With Goldman Sachs Asia Pacific Taiwan Computex Tour And Corporate Day
Goldman Sachs · Jun 9, 2026
Oric Pharmaceuticals Inc. Key Takeaways
Goldman Sachs · Jun 9, 2026
Australian Morning Focus
ANZ · Jun 9, 2026
Marketcolour and CPI Preview
Goldman Sachs · Jun 9, 2026
Apple Inc. WWDC 2026: Setting The Stage For The Agentic Smartphone Era
Bank of America · Jun 9, 2026
The Kevin Warsh Fed
TS Lombard · Jun 9, 2026
Kiniksa Pharmaceuticals Key Takeaways
Goldman Sachs · Jun 9, 2026
New Zealand Morning Focus
ANZ · Jun 9, 2026
Uranium Energy Corp. Operational Milestones
Goldman Sachs · Jun 9, 2026
Latam Daily
Scotiabank · Jun 9, 2026
Daily Points
Scotiabank · Jun 9, 2026
Will the IPO Wave Derail Equities
Deutsche Bank · Jun 9, 2026
Fixed Income Weekly Commentary
Nuveen · Jun 9, 2026
USA Economic Indicators Update
Goldman Sachs · Jun 9, 2026
Europe First to Market
J.P. Morgan · Jun 9, 2026
Oscar Health Inc Key Takeaways
Goldman Sachs · Jun 9, 2026
Daily Europe
UBS · Jun 9, 2026
AI Volatility Is Back But The Capex Story Still Looks Firm
UBS · Jun 9, 2026
United Kingdom Retail Supermarkets
Goldman Sachs · Jun 9, 2026
Hemab Therapeutics Holdings Strategic Interests and Market Opportunity in VWD
Goldman Sachs · Jun 9, 2026
Health Care Offers More Than a Defensive Role in Portfolios
UBS · Jun 9, 2026